27 Jul 2015

Inzitan (Dexametasona / Lidocaína / Tiamina / Cianocobalamina) - España

ATC: H02AB
SYSTEMIC HORMONAL PREP EXCLUDING SEX HORMONES
CORTICOSTEROIDS FOR SYSTEMIC USE
CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
GLUCOCORTICOIDS
Inzitan

Last Updated on 27 Jul 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

Inzitan Indication

Tratamiento sintomático de patología aguda dolorosa como lumbalgias, ciáticas, lumbociáticas; neuritis, polineuritis.

 

Inzitan Generic Name

Dexametasona / Lidocaína / Tiamina / Cianocobalamina

Type

POM

Summary Product Characteristics (SPCs) Links
Resumen de las Características del Producto - Inzitan (external site)

Related Learning Zones

Bedwetting Knowledge Centre and
Interactive Case Studies

Bedwetting Knowledge Centre and </br>Interactive Case Studies

The Bedwetting Knowledge Centre, independently reviewed for clinical accuracy by Søren Rittig, MD, DMSc, aims to equip healthcare professionals with the information and guidance they need to effectively diagnose, treat and refer patients with nocturnal enuresis. This mobile-optimised resource contains disease awareness information, best practice guidelines and interactive case studies: ‘Case Studies in Urology: Best Practice Management of Bedwetting’.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Inzitan Marketing Information

Inzitan Generic Name
Dexametasona / Lidocaína / Tiamina / Cianocobalamina
Marketing Company
KERN PHARMA, S.L.
Drug Type
POM
Date of Issue, Marketing Authority 01/01/1968

Related Drugs - Pain Management

Back to top